Evidence map›Paper›PMID 37768732›Full record

ArticleJCI insight2023

TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa.

Béatrice Bocquet, Caroline Borday, Nejla Erkilic, Daria Mamaeva, Alicia Donval, Christel Masson, Karine Parain, Karolina Kaminska, Mathieu Quinodoz, Irene Perea-Romero and 20 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. CLUAP1 variants cause non-syndromic retinitis pigmentosa.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  3. Article
  4. Ciliary Defects in Inherited Retinal Diseases.Advanced genetics (Hoboken, N.J.) · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Retinal Organoids: Innovative Tools for Understanding Retinal Degeneration.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Systematic review:Frontiers in medicine · 2025
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 7 institutions in 6 countries.

Béatrice BocquetInstitute for Neurosciences of Montpellier (INM), University of Montpellier, Inserm, Montpellier, France.
Caroline BordayUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France.
Nejla ErkilicInstitute for Neurosciences of Montpellier (INM), University of Montpellier, Inserm, Montpellier, France.
Daria MamaevaInstitute for Neurosciences of Montpellier (INM), University of Montpellier, Inserm, Montpellier, France.
Alicia DonvalUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France.
Christel MassonUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France.
Karine ParainUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France.
Karolina KaminskaInstitute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
Mathieu QuinodozInstitute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
Irene Perea-RomeroDepartment of Genetics, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Gema Garcia-GarciaCenter for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Carla Jimenez-MedinaInstitute for Neurosciences of Montpellier (INM), University of Montpellier, Inserm, Montpellier, France.
Hassan BoukhaddaouiInstitute for Neurosciences of Montpellier (INM), University of Montpellier, Inserm, Montpellier, France.
Arthur CogetDepartment of Neuroradiology and.
Nicolas LeboucqDepartment of Neuroradiology and.
Giacomo CalzettiInstitute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
Stefano GandolfiDepartment of Medicine and Surgery.
Antonio PercesepeDepartment of Medicine and Surgery.
Valeria BariliDepartment of Medicine and Surgery.
Vera UlianaDepartment of Medical Genetics.
Marco DelsanteDepartment of Nephrology, and.
Francesca BozzettiNeuroradiology Unit, Diagnostic Department, University Hospital of Parma, Parma, Italy.
Hendrik Pn SchollInstitute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
Marta CortonDepartment of Genetics, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Carmen AyusoDepartment of Genetics, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Jose M MillanCenter for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Carlo RivoltaInstitute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.
Isabelle MeunierInstitute for Neurosciences of Montpellier (INM), University of Montpellier, Inserm, Montpellier, France.
Muriel PerronUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France.
Vasiliki KalatzisInstitute for Neurosciences of Montpellier (INM), University of Montpellier, Inserm, Montpellier, France.
Inserm · FRUniversity of Parma · ITCentre National de la Recherche Scientifique · FRInstituto de Salud Carlos III · ESUniversity of Basel · CHCentre Hospitalier Universitaire de Montpellier · FRUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinitis pigmentosa (RP) is the most common inherited retinal disease (IRD) and is characterized by photoreceptor degeneration and progressive vision loss. We report 4 patients presenting with RP from 3 unrelated families with variants in TBC1D32, which to date has never been associated with an IRD. To validate TBC1D32 as a putative RP causative gene, we combined Xenopus in vivo approaches and human induced pluripotent stem cell-derived (iPSC-derived) retinal models. Our data showed that TBC1D32 was expressed during retinal development and that it played an important role in retinal pigment epithelium (RPE) differentiation. Furthermore, we identified a role for TBC1D32 in ciliogenesis of the RPE. We demonstrated elongated ciliary defects that resulted in disrupted apical tight junctions, loss of functionality (delayed retinoid cycling and altered secretion balance), and the onset of an epithelial-mesenchymal transition-like phenotype. Last, our results suggested photoreceptor differentiation defects, including connecting cilium anomalies, that resulted in impaired trafficking to the outer segment in cones and rods in TBC1D32 iPSC-derived retinal organoids. Overall, our data highlight a critical role for TBC1D32 in the retina and demonstrate that TBC1D32 mutations lead to RP. We thus identify TBC1D32 as an IRD-causative gene.

Indexed as

Induced Pluripotent Stem CellsRetinal DegenerationRetinitis PigmentosaAdaptor Proteins, Signal TransducingHumansRetinaRetinal Pigment EpitheliumAdaptor Proteins, Signal TransducingTBC1D32 protein, humanGenetic diseasesGeneticsiPS cellsOphthalmologyRetinopathy

Identifiers

PMID37768732
PMCPMC10721274
OpenAlexW4387115049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.